project id: TCGA-ACC; case submitter id: TCGA-OR-A5KZ; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.29; rna integrity number: 7.8; age at index: 42; days to birth: -15594; days to death: 125; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1970; year of death: 2012; age at diagnosis: 15594; ajcc clinical m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C74.0; last known disease status: not reported; morphology: 8370/3; primary diagnosis: Adrenal cortical carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cortex of adrenal gland; synchronous malignancy: No; tissue or organ of origin: Cortex of adrenal gland; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 319; initial weight: 120.0; sample id: 0c9c6928-ba38-49da-a5cf-67dd8e038f60; sample submitter id: TCGA-OR-A5KZ-01A; portion id: 9845b9ca-bdea-445f-a934-657bc595f8f2; portion submitter id: TCGA-OR-A5KZ-01A-11; slide id: f23007d2-8991-4788-8f34-2df56fd62dc7; slide submitter id: TCGA-OR-A5KZ-01A-01-TSA; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 19.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 81.0; percent tumor nuclei: 80.0; section location: TOP;